4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Coagulation Disorder: new trials by email Literature Review of Coagulation Disorder trials Research Report on Coagulation Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin VMX-C001, Rivaroxaban, UFH - Coagulation Disorder | Phase 1 | Completed | VarmX B.V. | 16 | 2024-08-14 | 2026-05-11 |
| Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant VMX-C001, Placebo, Rivaroxaban 20 mg Oral Tablet - Coagulation Disorder | Phase 1 | Completed | VarmX B.V. | 40 | 2024-02-21 | 2026-09-09 |
| Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects VMX-C001, Placebo, Apixaban - Coagulation Disorder | Phase 1 | Completed | VarmX B.V. | 105 | 2021-10-29 | 2023-06-02 |
| Anfibatide Phase 1 Clinical Trial in Healthy Volunteers Anfibatide - Coronary Heart Disease, Coagulation Disorder | Phase 1 | Completed | Lee's Pharmaceutical Limited | 94 | 2010-09-01 | 2012-04-30 |
Hemostatic Disorders (4) · Coronary Disease (1)
Cardiovascular Diseases (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Hemorrhagic Disorders (4) · Vascular Diseases (4) · Heart Diseases (1) · Myocardial Ischemia (1)
Rivaroxaban (3) · apixaban (2) · edoxaban (2) · Enoxaparin (1) · Tablets (1) · agkisacucetin protein, Agkistrodon acutus (1)
VarmX B.V. (3) · Lee's Pharmaceutical Limited (1)
Netherlands (3)
2023 (1)